Has the Brent Saunders price-hike limit become a de facto pharma rule?
admin 14th August 2017 Uncategorised 0Nearly one year ago, as the pharma industry was beset by pricing scrutiny, Allergan CEO Brent Saunders pledged to keep his company’s hikes under 10%. Since then, that pricing rule has spread—even among companies that haven’t publicly promised to do the same.
More: Has the Brent Saunders price-hike limit become a de facto pharma rule?
Source: fierce